Papillary thyroid carcinoma: Rationale for total thyroidectomy

Textbook of Endocrine Surgery

Volumn , Issue , 2005, Pages 110-114

  Clark, Orlo H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846439687     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0139-7.50016-8     Document Type: Chapter

References (65)

1. Clark OH, Levin K, Zeng QH, et al. Thyroid cancer: The case for total thyroidectomy. Eur J Cancer Clin Oncol 1988, 24:305.
2. Grossman RF, Tezelman S, Clark OH Thyroid cancer: The case for total thyroidectomy revisited. Head and Neck Cancer 1993, Vol III:879. Elsevier, Amsterdam, Excerpta Medica International, Congress Series. J.T. Johnson, M.S. Didolkar (Eds.).
3. Foster RS Morbidity and mortality after thyroidectomy. Surg Gynecol Obstet 1978, 146:423.
4. Harness JK, Fung L, Thompson NW, et al. Total thyroidectomy: Complications and technique. World J Surg 1986, 10:781.
5. Thompson NW, Nishiyama RH, Harness JK Thyroid carcinoma: Current controversies. Curr Probl Surg 1978, 15:1.
6. Cady B, Rossi R An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 1988, 104:948.
7. Hay ID, Grant CS, Taylor WF, McConahey WM Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987, 102:1088.
8. Clark OH Total thyroidectomy: The treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982, 196:361.
9. Attie JN, Moskowitz GW, Margouleff D, Levy LM Feasibility of total thyroidectomy in the treatment of thyroid carcinoma: Postoperative radioactive iodine evaluation of 140 cases. Am J Surg 1979, 138:555.
10. Thompson NW Total thyroidectomy in the treatment of thyroid carcinoma. Endocrine Surgery Update 1983, 71. Grune & Stratton, New York. N.W. Thompson, A.I. Vinik (Eds.).
11. Clark OH, Duh QY Thyroid cancer. Med Clin North Am 1991, 75:211.
12. DeGroot LJ, Kaplan EL, Shukla MS, et al. Morbidity and mortality in follicular thyroid carcinoma. J Clin Endocrinol Metab 1995, 80:2946.
13. Leung SF, Law MW, Ho SK Efficacy of low-dose iodine 131 ablation of postoperative thyroid remnants: A study of 69 cases. Br J Radiol 1992, 65:905.
14. Schlumberger M, Tubiana M, De Vathaire F, et al. Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab 1986, 63:960.
15. Simon D, Kohrle J, Schmutzler C, et al. Redifferentiation therapy of differentiated thyroid carcinoma with retinoic acid: Basics and first clinical results. Exp Clin Endocrinol Diabetes 1996, 104(Suppl 4):13.
16. Eigelberger MS, Wong MG, Duh QY, Clark OH Phenylacetate enhances the antiproliferative effect of retinoic acid in follicular thyroid cancer. Surgery 2001, 130:931.
17. Reeve TS, Delbridge L, Cohen A, Crummer P Total thyroidectomy: The preferred option for multinodular goiter. Ann Surg 1987, 206:782.
18. Liu Q, Gianakakis L, Djuricin G, Prinz R Total thyroidectomy for benign thyroid diseases. Surgery 1998, 123:27.
19. Kikuchi S, Perrier N, Ituarte P, et al. Accuracy of fine-needle aspiration cytology in patients with radiation-induced thyroid neoplasms. Br J Surg 2003, 90:755.
20. Russell WD, Ibanez ML, Clark RL, et al. Thyroid carcinoma: Classification, intraglandular dissemination, and clinicopathological study based upon whole-organ sections of 80 glands. Cancer 1963, 11:1425.
21. Noguchi S, Noguchi A, Murakami N Papillary carcinoma of the thyroid: I. Developing pattern of metastasis. Cancer 1970, 26:1053.
22. Kebebew E, Clark OH Locally advanced differentiated thyroid cancer. Surg Oncol 2003, 12:91.
23. Putti TC, Bhuiya TA Mixed columnar cell and tall cell variant of papillary carcinoma of thyroid: A case report and review of the literature. Pathology 2000, 32:286.
24. Vigneri R Studies on the goiter endemia in Sicily. J Endocrinol Invest 1988, 11:831.
25. Emerick GT, Duh QY, Siperstein AE, et al. Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer 1993, 72:3287.
26. Chong GC, Beahrs OH, Sizemore GW, Woolner LH Medullary carcinoma of the thyroid gland. Cancer 1975, 35:695.
27. Kushchayeva K, Duh QY, Kebebew E, Clark OH Hürthle cell cancer. World J Surg 2004, 28:1266.
28. Yutan E, Clark OH Hürthle cell carcinoma. Curr Treat Options Oncol 2001, 2:331.
29. Nishiyama RH, Dunn EL, Thompson NW Anaplastic spindle cell and giant cell tumors of the thyroid gland. Cancer 1972, 30:113.
30. Miura D, Wada N, Chin K, et al. Anaplastic thyroid cancers cytogenetic patterns by comparative genomic hybridization. Thyroid 2003, 13:282.
31. Cohn KH, Backdahl M, Forsslund G, et al. Biologic considerations and operative strategy in papillary thyroid carcinoma: Arguments against the routine performance of total thyroidectomy. Surgery 1984, 96:957.
32. Hay ID Prognostic factors in thyroid carcinoma. Thyroid Today 1989, 12:1.
33. Cady B, Rossi R, Silverman M, Wool M Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery 1985, 98:1171.
34. Hay ID Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990, 19:545.
35. Backdahl M, Carstensen J, Auer G, Tallroth E Statistical evaluation of the prognostic value of nuclear DNA content in papillary, follicular, and medullary thyroid tumors. World J Surg 1986, 10:974.
36. Siperstein AE, Zeng QH, Gum ET, et al. Adenylate cyclase activity as a predictor of thyroid tumor aggressiveness. World J Surg 1988, 12:528.
37. Beierwaltes WH, Nishiyama RH, Thompson NW, et al. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastases: Statistics following University of Michigan therapy. J Nucl Med 1982, 23:561.
38. Duh QY, Siperstein AE, Miller RA, et al. Epidermal growth factor receptors and adenylate cyclase activity in human thyroid tissues. World J Surg 1990, 14:410.
39. Clark OH, Duh QY Thyroid growth factors and oncogenes. Oncogenes and Tumor Suppressor Genes in Human Malignancies 1993, 87. Kluwer Academic, Norwell, MA. C.C. Benz, E.T. Liu (Eds.).
40. Goretzki PE, Lyons J, Stacy-Phipps S, et al. Mutational activation of RAS and GSP oncogenes in differentiated thyroid cancer and their biological implications. World J Surg 1992, 16:576.
41. Lemoine NR, Mayall ES, Wyllie FS, et al. Activated ras oncogenes in human thyroid cancers. Cancer Res 1988, 48:4459.
42. Santoro M, Dathan NA, Berlingieri MT, et al. Molecular characterization of RET/PTC3, a novel rearranged version of the RET protooncogene in a human thyroid papillary carcinoma. Oncogene 1994, 9:509.
43. Grossman RF, Tu SH, Duh QY, Siperstein AE, et al. Familial non-medullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg 1995, 130:892.
44. Hay ID, Thompson GB, Grant CS, et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2,444 consecutively treated patients. World J Surgery 2002, 26:879.
45. Grant CS, Hay ID, Gough IR, et al. Local recurrence in papillary thyroid carcinoma: Is extent of surgical resection important?. Surgery 1988, 104:954.
46. Cady B, Sedgwick CE, Meissner WA, et al. Risk factor analysis in differentiated thyroid cancer. Cancer 1979, 43:810.
47. Wanebo HJ, Andrews W, Kaiser DL Thyroid cancer: Some basic considerations. CA Cancer J Clin 1983, 33:87.
48. Farrar WB, Cooperman M, James AG Surgical management of papillary and follicular carcinoma of the thyroid. Ann Surg 1980, 192:701.
49. Schroder DM, Chambors A, France CJ Operative strategy for thyroid cancer: Is total thyroidectomy worth the price?. Cancer 1986, 58:2320.
50. Massin JP, Savoie JC, Garnier H, et al. Pulmonary metastases in differentiated thyroid carcinoma: Study of 58 cases with implications for the primary tumor treatment. Cancer 1984, 53:982.
51. DeGroot LJ, Kaplan EL, McCormick M, Straus FH Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990, 71:414.
52. Mazzaferri EL, Young RL Papillary thyroid carcinoma: A 10 year follow-up report of the impact of therapy in 576 patients. Am J Med 1981, 70:511.
53. Mazzaferri EL, Jhiang SM Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 1994, 97:418.
54. Loh KC, Greenspan F, Gee L, et al. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas. J Clin Endocrinol Metab 1997, 82:3553.
55. Wong JB, Kaplan MM, Meyer KB, Pauker SG Ablative radioactive iodine therapy for apparently localized thyroid carcinoma: A decision analytic perspective. Endocrinol Metab Clin North Am 1990, 19:741.
56. Kebebew E, Clark OH Differentiated thyroid cancer: "Complete" rational approach. World J Surg 2000, 24:942.
57. Esnaola NF, Cantor SB, Sherman SI, et al. Optimal treatment strategy in patients with papillary thyroid cancer: a decision analysis. Surgery 2001, 130:921.
58. Levin KE, Clark AH, Duh QY, et al. Reoperative thyroid surgery. Surgery 1992, 111:604.
59. Attie JN, Bock G, Auguste LJ Multiple parathyroid adenomas: Report of thirty-three cases. Surgery 1990, 108:1014.
60. Park HM, Perkins OW, Edmondson JW, et al. Influence of diagnostic radioiodines on the uptake of ablative dose of iodine 131. Thyroid 1994, 4:49.
61. Kebebew E, Duh QY, Clark OH Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: Surgical decision analysis of a controversy using a mathematical model. World Surg 2000, 24:1295-1302.
62. Perzik S The place of total thyroidectomy in the management of 909 patients with thyroid disease. Am J Surg 1976, 132:480.
63. Lennquist S Surgical strategy in thyroid carcinoma: A clinical review. Acta Chir Scand 1986, 152:321.
64. Pacini F, Cetani F, Miccoli P, et al. Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine. World J Surg 1994, 18:600.
65. Casara D, Rubello D, Saladini G, et al. Different features of pulmonary metastases in differentiated thyroid cancer: Natural history and multivariate statistical analysis of prognostic variables. J Nucl Med 1993, 34:1626.